Ayurvedic Concepts supplement claims in promo literature lead to warning letter.
This article was originally published in The Tan Sheet
Executive Summary
AYURVEDIC CONCEPTS PROMOS CONTAIN "NUMEROUS" DISEASE CLAIMS, making the company's dietary supplement products unapproved drugs, FDA determines in a June 18 warning letter to the supplement importer and distributor. The letter, which resulted from inspections of the company conducted by FDA investigators on Feb. 2 and March 9, follows an FDA "courtesy letter" sent to Houston-based Ayurvedic Concepts in early 1997 ("The Tan Sheet" March 24, 1997, p. 9). The two products cited in the "courtesy letter" -- GastriCare and Gasex - - also are listed in the recent warning letter.